Full-length cDNA nucleotide sequence of a serologically undetectable HLA-DQA1 allele: HLA-DQA1*'LA'

Tissue Antigens

Volumn 50, Issue 4, 1997, Pages 334-339

  Lardy, N M ^a,c   Otting, N ^b   Van Der Horst, A R ^a   Bontrop, R E ^b   De Waal, L P ^a  

^a Ctrl Lab Dutch Red Cross Blood   (Netherlands)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

cDNA; HLA DQ1; Sequence analysis; Serologically undetectable

Indexed keywords

COMPLEMENTARY DNA; HLA DQ ANTIGEN;

ALLELE; ARTICLE; DNA SEQUENCE; HAPLOTYPE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0030809998     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02883.x     Document Type: Article

References (26)

1. Campbell RD, Trowsdale J. Map of the human MHC. Immunol Today 1993: 14: 349-352.
2. Halloran PF, Wadgymar A, Autenried P. The regulation of major histocompatibility complex products. Transplantation 1986: 41: 413-420.
3. Leeuwenberg JFM, Van Damme J, Meager T, Jeunhomme TMAA, Buurman WA. Effects of tumor necrosis factor on the interferon-τ- induced major histocompatibility complex class II antigen expression by human endothelial cell. Eur J Immunol 1988: 18: 1469-1472.
4. Germain RN, Margulies DH. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 1993: 11: 403-450.
5. Germain RN. MHC dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994: 76: 287-299.
6. Cresswell P. Assembly, transport and function of MHC class II molecules. Annu Rev Immunol 1994: 12: 259-294.
7. López de Castro JA. Class I and class II HLA proteins and genes: an overview of structure, polymorphism, and expression. In: Solheim BG, Ferrone S, Möller E, ed. The HLA system in clinical transplantation. Berlin: Springer-Verlag, 1993.
8. Marsh SGE, Bodmer JG. HLA-DR and -DQ epitopes and monoclonal antibody specificity. Immunol Today 1989: 10: 305-311.
9. Kwok WW, Kovats S, Thurtle P, Nepom GT. HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation. J Immunol 1993: 150: 2263-2272.
10. Bidwell J, Bidwell E, Savage D, Middleton D, Klouda P, Bradley B. A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA DR and DQ alleles including DRwIO. Transplantation 1988: 45: 640-646.
11. Uryu N, Maeda M, Ota M, Tsuji K, Inoko H. A simple and rapid method for HLA-DRB and DQB typing by digestion of PCR-amplified DNA with allele specific restriction endonuclease. Tissue Antigens 1990: 35: 20-31.
12. Horton VA, Bunce M, Davies DR, Turner RC, Lo YM. HLA typing for DR3 and DR4 using artificial restriction fragment length polymorphism PCR from archival DNA. J Clin Pathol 1995: 48: 33-36.
13. Tiercy J-M, Goumaz C, Mach B, Jeannet M. Application of HLA-DR oligotyping to 110 kidney transplant patients with doubtful serological typing. Transplantation 1991: 51: 1110-1114.
14. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992: 39: 225-235.
15. Bunce M, Taylor CJ, Welsh KI. Rapid HLA-DQB typing by eight PCR amplifications with sequence-specific primers (PCR-SSP). Hum Immunol 1993: 37: 201-206.
16. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993: 41: 119-134.
17. Rozemuller EH, Chadwick B, Charron D et al. Sequenase sequence profiles used for HLA-DPB1 sequencing-based typing. Tissue Antigens 1996: 47: 72-79.
18. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1996. Tissue Antigens 1997: 49: 297-321.
19. Falk JA, WillShire AM, Bodmer JG, et al. Antigen Society #27 report (DQw1). In: Dupont B, ed. Immunobiology of HLA. Histocompatibility testing 1987. Volume I. New York: Springer-Verlag, 1989: 266-268.
20. Tait BD, Park MS, Barbetti A, Langley J, Terasaki PI, Aizawa M. Antigen Society #28 report (DQw3). In: Dupont B. ed. Immunobiology of HLA. Histocompatibility testing 1987. Volume I. New York: Springer-Verlag, 1989: 269-273.
21. Kimura A, Sasazuki T. Eleventh international Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Volume 1. Oxford: Oxford University Press. 1992: 397-419.
22. Miller SN, Fernandez-Viña MA, Stastny P. Serology and DNA typing for HLA class II in North American Indians and Blacks. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Volume 2. Oxford: Oxford University Press, 1992: 235-237.
23. Lee KW, Johnson AH, Hurley CK. New DQw1 diversity identified within DRw12 and DRw14 haplotypes. Tissue Antigens 1991: 38: 231-234.
24. Fogdell A, Olerup O. The DQA1*0104 allele is carried by DRB1*1001- and DRB1*1401-positive haplotypes in Caucasians, Africans and Orientals. Tissue Antigens 1994: 44: 19-24.
25. Marsh SGE, Bodmer JG. HLA class II region nucleotide sequences, 1995. Tissue Antigens 1995: 45: 258-280.
26. Lardy NM, Bakas RM, Horst van der AR, Twuyver van E, Bontrop RE, Waal de LP. Cis-acting regulatory elements abrogate allele-specific HLA class I gene expression in healthy individuals. J Immunol 1992: 148: 2572-2577.